Utility of ECG-Vision for Surveillance of Left Ventricular Dysfunction in Patients With Hypertrophic Cardiomyopathy

Aakash Bavishi1, John Fritzlen2, Marybeth Soutar3

  • 1University of Illinois-Chicago (A.B.).

Insights

Artificial intelligence (AI)-enabled ECGs show promise in predicting left ventricular systolic dysfunction (LVSD) in hypertrophic cardiomyopathy patients on mavacamten. This AI tool could reduce the need for frequent echocardiograms, improving access to care.

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Obstructive hypertrophic cardiomyopathy (HCM) requires frequent monitoring for left ventricular systolic dysfunction (LVSD) using transthoracic echocardiograms (TTEs).
  • Current monitoring methods can be burdensome and limit access, particularly in rural or underserved areas.
  • Mavacamten is a myosin inhibitor used to treat obstructive HCM.

Purpose of the Study:

  • To evaluate the performance of an artificial intelligence (AI)-enabled ECG tool in predicting LVSD in patients with obstructive HCM treated with mavacamten.
  • To assess the potential of AI-ECG as an alternative or adjunctive tool to TTE for LVSD monitoring.

Main Methods:

  • A cohort of 147 patients with obstructive HCM initiated on mavacamten underwent paired ECG and TTE at baseline and follow-up.
  • A validated AI-enabled ECG algorithm was used to predict the probability of LVSD (defined as left ventricular ejection fraction <50%).
  • Sensitivity, specificity, positive predictive value, negative predictive value, and AUC were calculated, accounting for repeated measures.

Main Results:

  • The AI-enabled ECG demonstrated high sensitivity (100%) and negative predictive value (100%) for detecting LVSD at a 20% probability threshold.
  • The area under the curve (AUC) was 0.94, indicating strong predictive performance.
  • Patient-level classification concordance between AI-ECG and TTE was 86%.

Conclusions:

  • AI-enabled ECG tools show high sensitivity and NPV for detecting LVSD in obstructive HCM patients on mavacamten.
  • While estimates were imprecise due to infrequent LVSD events, findings support AI-ECG as a potential adjunctive triage tool.
  • Prospective, multicenter validation is recommended to confirm these exploratory findings.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...